|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10,880.00 JPY | +6.77% |
|
+7.88% | +22.62% |
| 03-04 | Irlab Working to Secure Funding for Phase 3 Study of Mesdopetam - fc | FW |
| 02-26 | Irlab Receives $3 Million Milestone Payment Following Dosing in Phase 1b Study | FW |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 1.4% | 1.51% | 18.62x | 1.66x | 1.95x | 9.56x | 12.73x | 34.11B | ||
| 0.82% | 0.92% | 37.27x | 5.41x | 7.1x | 24.31x | 29.51x | 47.36B | ||
| 1.03% | 1.05% | 25.71x | 3.12x | 3.47x | 16.4x | 20.21x | 11.73B | ||
| 0.88% | 0.87% | 20.44x | 3.33x | 3.54x | 13.2x | 15.94x | 10.11B | ||
| 1% | 1.09% | 89.72x | 6.95x | - | - | - | 8.76B | ||
| 3.59% | 3.92% | 18.7x | 3.12x | 3.2x | 11.87x | 14.29x | 8.16B | ||
| 3.24% | 3.25% | 16.33x | 1.39x | 2.11x | 7.97x | 10.68x | 7.18B | ||
| 0.13% | 0.15% | 35.11x | 6.07x | 3.82x | 17.36x | 18.19x | 6.84B | ||
| 4.52% | 5.1% | 9.41x | 1.52x | 2.05x | 5.55x | 6.67x | 6.46B | ||
| 0.21% | 0.21% | 39.79x | 5.38x | 4.34x | 19.66x | 27.42x | 4.42B | ||
| 1.11% | 1.28% | 35.33x | 8.32x | 6.81x | 25.06x | 27.95x | 4.08B | ||
| 2.35% | 2.94% | 20.81x | 3.32x | 3.48x | 16.72x | 20.34x | 3.95B | ||
| 1.57% | 1.93% | 13.45x | 0.69x | 2.12x | 8.97x | 11.43x | 3.81B | ||
| 2.56% | 2.82% | 15.64x | 3.62x | 3.69x | 13.2x | 14.47x | 2.91B | ||
| 3.07% | 3.25% | 19.55x | 5.37x | 6.24x | 17.81x | 18.94x | 2.53B | ||
| Average | 1.83% | 2.02% | 27.73x | 3.95x | 3.85x | 14.83x | 17.77x | 10.83B | |
| Weighted average by Cap. | 1.45% | 1.58% | 29.64x | 3.87x | 4.26x | 16.17x | 19.79x |
- Stock Market
- Equities
- 4578 Stock
- Sector Otsuka Holdings Co., Ltd.
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















